Education, International, EUGLOH, Research
SPOC MIRACIP : Management of immunorelated complication of cancer immunotherapy - Spring 2026
… SPOC MIRACIP : Management of immunorelated complication of cancer immunotherapy - Spring 2026 … are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … those of traditional cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be …
Published on: